A Modified Omental Patch Work Decreases Pancreatic Fistula After Lpd

Sponsor
Zhejiang Provincial People's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04704882
Collaborator
(none)
162
1
2
16.9
9.6

Study Details

Study Description

Brief Summary

Pancreaticoduodenecotmy(PD) is considered as the standard procedure for peri-amplullary or pancreatic head tumors. Laparoscopic pancreaticoduodenctomy(LPD) has been reported with minimal invasive advantages, such as small incision, less blood loss, less pain, et al. Further, some trials showed LPD got less morbidity and shorter length of stay. Pancreatic fistula is the major complication for pancreaticodupdenectomy and associated with numerous serious complications, suffering reoperation or sometimes death. The reported rate was 10% to 55%. A lot of modified procedure have been proposed to reduce pancreatic fistula. Omental flaps around anastomosis have been used to prevent post pancreaticoduodenectomy fistula or hemorrhage. However, the outcomes are controversy. A modified omental patch work has been used during LPD and the initial outcomes are good. This is a pilot study to evaluate the function of the modified omental patch work on decreasing the pancreatic fistula.

Condition or Disease Intervention/Treatment Phase
  • Other: omental patchwork
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
162 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
A Modified Omental Patch Work Decreases Pancreatic Fistula After Laparoscopic Pancreaticoduodenectomy
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
May 31, 2022
Anticipated Study Completion Date :
May 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: omental patchwork group

Other: omental patchwork
the omental flaps were sewn to lesser omentum and hepatorenal ligament to cover all the vessels

No Intervention: non-omental patchwork group

Outcome Measures

Primary Outcome Measures

  1. pancreatic fistula [90 days]

    Incidence of pancreatic fistula grade B/C defined by ISGPF classification

Secondary Outcome Measures

  1. morbidity [90 days]

  2. Mortality [90 days]

  3. Postoperative hospital stay [90 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. . Disease of periampullary or pancreatic head tumor

  2. . Age: 18 years or older

  3. Distant metastases are not diagnosed preoperatively.

  4. . Patients who can provide written informed consent

Exclusion Criteria:
  1. . Patients with severe organ disease such as cardiac disease,respiratory illness

  2. . Patients with extended LPD or vessels reconstruction

  3. Patients with conversion to laparotomy

  4. . Patients with pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhejiang Provincial People'S Hospital Hangzhou Zhejiang China 314000

Sponsors and Collaborators

  • Zhejiang Provincial People's Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yi-Ping Mou, Professor, Zhejiang Provincial People's Hospital
ClinicalTrials.gov Identifier:
NCT04704882
Other Study ID Numbers:
  • ZJPPHGIP-RCT2019001
First Posted:
Jan 12, 2021
Last Update Posted:
Dec 8, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 8, 2021